Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature
- PMID: 27350324
- DOI: 10.1007/s11046-016-0021-8
Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature
Abstract
Mucormycosis and aspergillosis are two opportunistic fungal infections, which can evolve into life-threatening complications. They generally affect patients with relevant risk factors such as immunocompromisation or long-term use of antibiotics or corticosteroids. Treatment usually combines medical and surgical approaches, often including extended necrosectomies, although the prognosis of generalized fungal infections is very poor. In this paper, we present the case of a 17-year-old girl affected by combined aspergillosis and mucormycosis, following treatment of a recurrent glioma. The patient was hospitalized for a suspected cellulitis of the right hemi-face, involving frontal maxillary area and the upper airways and was immediately put on intravenous antibiotic therapies; after performing nasal septum and maxillary biopsies, concomitant mucormycosis and aspergillosis were diagnosed and antimycotic therapy with liposomal B-amphotericin was administered. After evaluation by the oral surgeon and otolaryngologist, surgical cranio-facial necrosectomy was suggested, but refused by the parents of the patient. The girl died only few days later, due to a respiratory arrest. Awareness of this pathology with prompt diagnosis and early treatment may improve the outcome of these infections and reduce the mortality.
Keywords: Aspergillosis; Early diagnosis; Invasive fungal infection; Mucormycosis.
Similar articles
-
Fatal mucormycosis and aspergillosis coinfection associated with haemophagocytic lymphohistiocytosis: A case report and literature review.J Mycol Med. 2023 Mar;33(1):101325. doi: 10.1016/j.mycmed.2022.101325. Epub 2022 Aug 8. J Mycol Med. 2023. PMID: 36270214 Review.
-
Invasive mucormycosis and aspergillosis in a healthy 22-year-old battle casualty: case report.Surg Infect (Larchmt). 2011 Oct;12(5):397-400. doi: 10.1089/sur.2010.065. Epub 2011 Oct 17. Surg Infect (Larchmt). 2011. PMID: 22004440
-
[Coinfection of rhinocerebral mucormycosis and sinus aspergillosis].Rev Peru Med Exp Salud Publica. 2015 Oct;32(4):813-7. Rev Peru Med Exp Salud Publica. 2015. PMID: 26732934 Spanish.
-
[Mixed invasive fungal infection due to Rhizomucor pusillus and Aspergillus niger in an immunocompetent patient].Rev Iberoam Micol. 2015 Jan-Mar;32(1):46-50. doi: 10.1016/j.riam.2013.03.002. Epub 2013 Apr 11. Rev Iberoam Micol. 2015. PMID: 23583263 Spanish.
-
Maxillary necrosis by mucormycosis. a case report and literature review.Med Oral Patol Oral Cir Bucal. 2007 Sep 1;12(5):E360-4. Med Oral Patol Oral Cir Bucal. 2007. PMID: 17767099 Review.
Cited by
-
Pulmonary aspergillosis, mucormycosis, and actinomycosis co-infection presenting as a cavitary lesion in a patient with diabetes.Chin Med J (Engl). 2019 Oct 20;132(20):2512-2513. doi: 10.1097/CM9.0000000000000468. Chin Med J (Engl). 2019. PMID: 31613818 Free PMC article. No abstract available.
-
Atypical presentations of fungal osteomyelitis during post COVID-19 outbreak - Case series.J Oral Maxillofac Surg Med Pathol. 2022 Sep;34(5):622-627. doi: 10.1016/j.ajoms.2022.03.007. Epub 2022 Apr 4. J Oral Maxillofac Surg Med Pathol. 2022. PMID: 35402152 Free PMC article.
-
Mucormycotic osteomyelitis of maxilla post-COVID patient: a case report.Pan Afr Med J. 2021 Aug 27;39:275. doi: 10.11604/pamj.2021.39.275.30480. eCollection 2021. Pan Afr Med J. 2021. PMID: 34754352 Free PMC article.
-
The Curious Case of "Case Report" of Infections Caused by Human and Animal Fungal Pathogens: An Educational Tool, an Online Archive, or a Format in Need of Retooling.Mycopathologia. 2018 Dec;183(6):879-891. doi: 10.1007/s11046-018-0314-1. Mycopathologia. 2018. PMID: 30570717
-
COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: A Proposed Classification and Treatment Strategies.Infect Disord Drug Targets. 2022;22(8):1-7. doi: 10.2174/1871526522666220408110135. Infect Disord Drug Targets. 2022. PMID: 35400327
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical